Citation Impact
Citing Papers
Point-of-Care Testing
2012 Standout
Recombinant antibodies encoded by IGHV1-69 react with pUL32, a phosphoprotein of cytomegalovirus and B-cell superantigen
2012
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Cancer statistics, 2018
2018 Standout
Liver fibrosis – from bench to bedside
2003 Standout
Hepatitis B virus reactivation associated with antirheumatic therapy: Risk and prophylaxis recommendations
2015
Immunorestitution Disease Involving the Innate and Adaptive Response
2000
A review of transfusion risks and optimal management of perioperative bleeding with cardiac surgery
2008
Validation of an automated immunoglobulin G–only cytomegalovirus (CMV) antibody screening assay and an assessment of the risk of transfusion transmitted CMV from seronegative blood
2008
Hepatitis B virus infection
2009 Standout
Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
2004 Standout
Inflammaging and anti-inflammaging: A systemic perspective on aging and longevity emerged from studies in humans
2006 Standout
Management of Hepatocellular Carcinoma *
2005 Standout
Hepatitis B reactivation after chemotherapy: two decades of clinical research
2008
Influenza Viral RNA Detection in Blood as a Marker to Predict Disease Severity in Hematopoietic Cell Transplant Recipients
2012
Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: A prospective study of 626 patients with identification of risk factors
2000
Chronic hepatitis B
2007 Standout
Management of the HBV reactivation in isolated HBcAb positive patients affected with Non Hodgkin Lymphoma
2014
Zika Virus Outbreak on Yap Island, Federated States of Micronesia
2009 Standout
Comprehensive analysis of risk factors associating with Hepatitis B virus (HBV) reactivation in cancer patients undergoing cytotoxic chemotherapy
2004
Chronic hepatitis B: Update 2009 #
2009 Standout
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
The Prevalence and Source of Toxoplasma Infection in the Environment
1989
Risks associated with transfusion of cellular blood components in canada
2003
The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation
2018 Standout
Seroprevalence of six different viruses among pregnant women and blood donors in rural and urban Burkina Faso: A comparative analysis
2006
Current incidence and estimated residual risk of transfusion‐transmitted infections in donations made to Canadian Blood Services
2007
Pathogen Reduction: A Precautionary Principle Paradigm
2008
Long–Term Follow–Up of Interferon Alfa Treatment in Chinese Patients With Chronic Hepatitis B Infection: the Effect on Hepatitis B E Antigen Seroconversion and the Development of Cirrhosis–Related Complications
2001
Toxoplasma gondii: from animals to humans
2000 Standout
Prevalence of anti-Toxoplasma gondii antibodies in the population of the area of Parma (Italy)
1995
Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms
2013 Standout
Refining the Global Spatial Limits of Dengue Virus Transmission by Evidence-Based Consensus
2012 Standout
Virus and Antibody Dynamics in Acute West Nile Virus Infection
2008
Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy
1991
Why do viruses cause cancer? Highlights of the first century of human tumour virology
2010
Immunity to fungal infections
2011 Standout
Chronic Cytomegalovirus Infection and Inflammation Are Associated with Prevalent Frailty in Community‐Dwelling Older Women
2005
Reactivation of hepatitis B virus with rituximab
2005
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion
2016 Standout
Simultaneous Visual Detection of Multiple Viral Amplicons by Dipstick Assay
2005
Treatment of Hepatitis C
2014
Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System?
2019 Standout
Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention
2009 Standout
Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy
2006
Point-of-Care Diagnostics for Global Health
2008 Standout
Prevention of hepatitis C virus infection using a broad cross‐neutralizing monoclonal antibody (AR4A) and epigallocatechin gallate
2015 StandoutNobel
KSHV INFECTION AND THE PATHOGENESIS OF KAPOSI'S SARCOMA
2006
Fibrosing cholestatic hepatitis in a hepatitis B surface antigen carrier after renal transplantation
1994
Hepatitis B Reactivation in Patients With Previous Hepatitis B Virus Exposure Undergoing Rituximab-Containing Chemotherapy for Lymphoma: A Prospective Study
2014
Why, When, and How to Prevent Hepatitis B Virus Reactivation in Cancer Patients Undergoing Chemotherapy
2011
Somatic Hypermutations Confer Rheumatoid Factor Activity in Hepatitis C Virus–Associated Mixed Cryoglobulinemia
2013 StandoutNobel
Steroid–Free Chemotherapy Decreases Risk of Hepatitis B Virus (Hbv) Reactivation in Hbv–Carriers With Lymphoma
2003
Works of Deborah Todd being referenced
Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti‐HBc: implications for transfusion transmission and donor screening
2003
The 2003 West Nile virus United States epidemic: the America's Blood Centers experience
2005
Genetic Diversity of Recently Acquired and Prevalent HIV, Hepatitis B Virus, and Hepatitis C Virus Infections in US Blood Donors
2012
Multicenter comparison of serologic assays and estimation of human herpesvirus 8 seroprevalence among US blood donors
2003
Multicenter evaluation of PCR methods fordetecting CMV DNA in blood donors
2001
CMV DNA is rarely detected in healthy blood donors using validated PCR assays
2003
Prevalence of Toxoplasma gondii antibodies in the Chinese population of Hong Kong
1980
Fatal reactivation of chronic hepatitis B virus infection following withdrawal of chemotherapy in lymphoma patients.
1989
Sensitive Detection Assays for Influenza RNA Do Not Reveal Viremia in US Blood Donors
2012